levodopa-induced dyskinesia

Ipsen bets up to $363M on another shot at a debilitating condition related to Parkinson's disease
Endpoints
Thu, 07/15/21 - 11:50 pm
Ipsen
levodopa-induced dyskinesia
IRLAB
Trevi Therapeutics jumps on the biotech IPO train
Fierce Biotech
Mon, 04/8/19 - 09:47 am
IPOs
Trevi Therapeutics
idiopathic pulmonary fibrosis
levodopa-induced dyskinesia
chronic pruritus